Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001193125-26-051409·Canaan XI L.P.
Schedule 13G ownership disclosure
Tyra Biosciences Inc
COMMON STOCK, $0.0001 PAR VALUE PER SHARE · CUSIP: 90240B106
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Canaan XI L.P.
Shares: 2,930,444 · Class: 5.5%
- Canaan Partners XI LLC
Shares: 2,930,444.00 · Class: 5.5%
- Canaan 2020+ Co-Investment L.P. - Series 7
Shares: 443,885.00 · Class: 0.8%
- Canaan Partners 2020+ Co-Investment LLC
Shares: 443,885.00 · Class: 0.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-051409
- Form type
- SCHEDULE 13G/A
- Filer
- Canaan XI L.P.
- CIK
- CIK 1712417
- Filed
- Feb 13, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership